These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8607393

  • 1. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M, Cullen MT, Casadei G.
    Am J Cardiol; 1996 Jan 25; 77(3):60A-75A. PubMed ID: 8607393
    [Abstract] [Full Text] [Related]

  • 2. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec 25; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E, Denjoy I.
    Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
    [Abstract] [Full Text] [Related]

  • 4. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P, Botto GL, Baldi N.
    Ital Heart J Suppl; 2005 Jun 25; 6(6):335-40. PubMed ID: 16013424
    [Abstract] [Full Text] [Related]

  • 5. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G.
    N Engl J Med; 2004 Dec 02; 351(23):2384-91. PubMed ID: 15575054
    [Abstract] [Full Text] [Related]

  • 6. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV, Dorian P, Hohnloser SH, Coumel P.
    Am J Cardiol; 1996 Jan 25; 77(3):53A-59A. PubMed ID: 8607392
    [Abstract] [Full Text] [Related]

  • 7. Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting.
    Kovacs B, Yakupoglu HY, Eriksson U, Krasniqi N, Duru F.
    Cardiol J; 2023 Jan 25; 30(1):82-90. PubMed ID: 36510792
    [Abstract] [Full Text] [Related]

  • 8. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
    J Intern Med; 1996 Mar 25; 239(3):253-60. PubMed ID: 8772625
    [Abstract] [Full Text] [Related]

  • 10. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
    Alboni P, Botto GL, Boriani G, Russo G, Pacchioni F, Iori M, Pasanisi G, Mancini M, Mariconti B, Capucci A.
    Heart; 2010 Apr 25; 96(7):546-9. PubMed ID: 20350992
    [Abstract] [Full Text] [Related]

  • 11. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
    Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M.
    Europace; 2011 Mar 25; 13(3):329-45. PubMed ID: 21227948
    [Abstract] [Full Text] [Related]

  • 12. Management of patients with acute atrial fibrillation in the ED.
    Conti A, Del Taglia B, Mariannini Y, Pepe G, Vanni S, Grifoni S, Abbate R, Michelucci A, Padeletti L, Gensini GF.
    Am J Emerg Med; 2010 Oct 25; 28(8):903-10. PubMed ID: 20825922
    [Abstract] [Full Text] [Related]

  • 13. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T.
    Clin Cardiol; 1996 May 25; 19(5):409-12. PubMed ID: 8723601
    [Abstract] [Full Text] [Related]

  • 14. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
    Camm AJ, Savelieva I.
    BMJ; 2007 Mar 24; 334(7594):637. PubMed ID: 17379911
    [No Abstract] [Full Text] [Related]

  • 15. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.
    Kingma JH, Suttorp MJ.
    Am J Cardiol; 1992 Aug 20; 70(5):56A-60A; discussion 60A-61A. PubMed ID: 1510000
    [Abstract] [Full Text] [Related]

  • 16. [Propafenone, flecainide, procainamide in the treatment of a fresh attack of atrial fibrillation].
    Kosmala W, Kucharski W, Haczyński J, Kobusiak-Prokopowicz M.
    Wiad Lek; 1994 Aug 20; 47(21-24):801-7. PubMed ID: 8999690
    [Abstract] [Full Text] [Related]

  • 17. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
    Romano S, Fattore L, Toscano G, Corsini F, Coppo A, Catanzaro M, Romano A, Martone A, Caccavale F, Iodice E, Di Maggio O, Corsini G.
    Ital Heart J Suppl; 2001 Jan 20; 2(1):41-5. PubMed ID: 11216083
    [Abstract] [Full Text] [Related]

  • 18. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ, Kingma JH, Jessurun ER, Lie-A-Huen L, van Hemel NM, Lie KI.
    J Am Coll Cardiol; 1990 Dec 20; 16(7):1722-7. PubMed ID: 2123909
    [Abstract] [Full Text] [Related]

  • 19. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
    Boriani G, Biffi M, Capucci A, Botto G, Broffoni T, Ongari M, Trisolino G, Rubino I, Sanguinetti M, Branzi A, Magnani B.
    Pacing Clin Electrophysiol; 1998 Nov 20; 21(11 Pt 2):2470-4. PubMed ID: 9825369
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
    Martínez-Sellés M, Castillo I, Montenegro P, Martín ML, Almendral J, Sanjurjo M.
    Rev Esp Cardiol; 2005 Jun 20; 58(6):745-8. PubMed ID: 15970126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.